Adagene (ADAG) Other Non-Current Assets (2019 - 2025)
Adagene's (ADAG) quarterly Other Non-Current Assets came in at $25.2 billion in Q4 2025, down 69.01% year-on-year from $81.4 billion in Q4 2024, and up 67369023.93% on a QoQ basis from $37440.0 in Q2 2025.
Adagene (ADAG) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Other Non-Current Assets data on file, last reported at $25.2 billion in Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 69.01% year-over-year to $25.2 billion in Q4 2025; TTM through Dec 2025 was $25.2 billion, a 69.01% decrease from a year earlier, with the FY2025 full-year figure at $25.2 billion, down 69.01% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $25.2 billion, up from $37440.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for ADAG reached as high as $109.6 billion in Q4 2022 and fell as low as $37440.0 in Q2 2025.
- Historically, Other Non-Current Assets has averaged $48.3 billion across 5 years, with a median of $49.0 billion in 2022.
- Across the five-year window, Other Non-Current Assets soared 158169513.86% in 2022 and slumped 100.0% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $69275.0 in 2021, then surged by 158169513.86% to $109.6 billion in 2022, then retreated by 22.53% to $84.9 billion in 2023, then dropped by 4.12% to $81.4 billion in 2024, then slumped by 69.01% to $25.2 billion in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $25.2 billion in Q4 2025, $37440.0 in Q2 2025, and $81.4 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 25.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.22 Bn |
| Jun 30, 2025 | 37,440.00 |
| Dec 31, 2024 | 81.39 Bn |
| Jun 30, 2024 | 281,881.00 |
| Dec 31, 2023 | 84.89 Bn |
| Jun 30, 2023 | 108.92 Bn |
| Dec 31, 2022 | 109.57 Bn |
| Jun 30, 2022 | 72.80 Bn |
| Dec 31, 2021 | 69,275.00 |
| Jun 30, 2021 | 59,569.00 |
| Dec 31, 2020 | 3.10 Mn |
| Dec 31, 2019 | 87,227.00 |